FibroGen Inc - Company Profile
Powered by 
All the data and insights you need on FibroGen Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date FibroGen Inc Strategy Report
- Understand FibroGen Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
FibroGen Catalyst Calendar
Proactively evaluate FibroGen Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of FibroGen Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 07 Nov 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 07 Nov 2019 | Phase III Trial Results | Astellas Pharma Inc; AstraZeneca Plc; FibroGen Inc; Novotech Australia Pty Ltd | 4503; AZN; FGEN | roxadustat | Hematological Disorders | Anemia; Anemia in Chronic Kidney Disease (Renal Anemia) | Company Press Release |
| 01 Oct 2019 | Phase I Trial Completion | Astellas Pharma Inc; FibroGen Inc | 4503; FGEN | roxadustat | Hematological Disorders | Anemia; Anemia in Chronic Kidney Disease (Renal Anemia) | Clinical Trial Registry |
| 13 Sep 2019 | Phase III Trial Completion | Astellas Pharma Inc; FibroGen Inc | 4503; FGEN | roxadustat | Genito Urinary System And Sex Hormones; Hematological Disorders | Anemia in Chronic Kidney Disease (Renal Anemia); Chronic Kidney Disease (Chronic Renal Failure) | Company Reports |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer